Inhibition of p38 MAPK sensitizes tumour cells to cisplatin-induced apoptosis mediated by reactive oxygen species and JNK.
Inhibition of p38 MAPK sensitizes tumour cells to cisplatin-induced apoptosis mediated by reactive oxygen species and JNK.
复制标题
DOI:
10.1002/emmm.201302732
复制
发表时间:
2013-11
影响因子:
11.1
通讯作者:
Nebreda, Angel R.
中科院分区:
文献类型:
--
作者:
Pereira, Lorena;Igea, Ana;Canovas, Begona;Dolado, Ignacio;Nebreda, Angel R.
The p38 MAPK pathway is an important regulator of many cellular responses. It is well established that p38 MAPK signalling negatively regulates epithelial cell transformation, but enhanced p38 MAPK activity has been also correlated with bad clinical prognosis in some tumour types. Here, we provide genetic and pharmacological evidence showing that p38 MAPK inhibition cooperates with the chemotherapeutic agent cisplatin to kill tumour cells. We show that p38 MAPK inhibition results in ROS upregulation, which in turn activates the JNK pathway via inactivation of phosphatases, sensitizing human tumour cells to cisplatin-induced apoptosis. Using a mouse model for breast cancer, we confirm that inhibition of p38 MAPK cooperates with cisplatin treatment to reduce tumour size and malignancy in vivo. Taken together, our results illustrate a new function of p38 MAPK that helps tumour cells to survive chemotherapeutic drug treatments, and reveal that the combination of p38 MAPK inhibitors with cisplatin can be potentially exploited for cancer therapy.
登录
查看更多内容
影响因子:
11.2
作者:
Chen L;Mayer JA;Krisko TI;Speers CW;Wang T;Hilsenbeck SG;Brown PH
通讯作者:
Brown PH
影响因子:
30.8
作者:
Hui, Lijian;Bakiri, Latifa;Wagner, Erwin F.
通讯作者:
Wagner, Erwin F.
影响因子:
5.7
作者:
Demuth, Tim;Reavie, Linsey B.;Berens, Michael E.
通讯作者:
Berens, Michael E.
影响因子:
50.3
作者:
Dolado, Ignacio;Swat, Aneta;Nebreda, Angel R.
通讯作者:
Nebreda, Angel R.
影响因子:
11.4
作者:
Joaquin, Manel;Gubern, Albert;Gonzalez-Nunez, Daniel;Josue Ruiz, E.;Ferreiro, Isabel;de Nadal, Eulalia;Nebreda, Angel R.;Posas, Francesc
通讯作者:
Posas, Francesc